Site Specific Discrete PEGylation of 124I-Labeled mCC49 Fab′ Fragments Improves Tumor MicroPET/CT Imaging in Mice
Authors:
- Rich BrodyRBRich Brody
- Paul D. DavisPDPaul D. Davis
- Mitchell PhelpsMPMitchell Phelps
- 31 October 2013
- journal article
- research article
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 24 (11) , 1945-1954
Abstract
The tumor-associated glycoprotein-72 (TAG-72) antigen is highly overexpressed in various human adenocarcinomas and anti-TAG-72 monoclonal antibodies, and fragments are therefore useful as pharmaceutical targeting vectors. In this study, we investigated the effects of site-specific PEGylation with MW 2–4 kDa discrete, branched PEGylation reagents on mCC49 Fab′ (MW 50 kDa) via in vitro TAG72 binding, and in vivo blood clearance kinetics, biodistribution, and mouse tumor microPET/CT imaging. mCC49Fab′ (Fab′-NEM) was conjugated at a hinge region cysteine with maleimide-dPEG 12-(dPEG24COOH)3 acid (Mal-dPEG-A), maleimide-dPEG12-(dPEG12COOH)3 acid (Mal-dPEG-B), or maleimide-dPEG12-(m-dPEG24)3 (Mal-dPEG-C), and then radiolabeled with iodine-124 (124I) in vitro radioligand binding assays and in vivo studies used TAG-72 expressing LS174T human colon carcinoma cells and xenograft mouse tumors. Conjugation of mCC49Fab′ with Mal-dPEG-A (Fab′-A) reduced the binding affinity of the non PEGylated Fab′ by 30%; however, in vivo, Fab′-A significantly lengthened the blood retention vs Fab′-NEM (47.5 vs 28.1%/ID at 1 h, 25.1 vs 8.4%/ID at 5 h, p < 0.01), showed excellent tumor to background, better microPET/CT images due to higher tumor accumulation, and increased tumor concentration in excised tissues at 72 h by 130% (5.09 ± 0.83 vs 3.83 ± 1.50%ID/g, p < 0.05). Despite the strong similarity of the three PEGylation reagents, PEGylation with Mal-dPEG-B or -C reduced the in vitro binding affinity of Fab′-NEM by 70%, blood retention, microPET/CT imaging tumor signal intensity, and residual 72 h tumor concentration by 49% (3.83 ± 1.50 vs 1.97 ± 0.29%ID/g, p < 0.05) and 63% (3.83 ± 1.50 vs 1.42 ± 0.35%ID/g, p < 0.05), respectively. We conclude that remarkably subtle changes in the structure of the PEGylation reagent can create significantly altered biologic behavior. Further study is warranted of conjugates of the triple branched, negatively charged Mal-dPEG-A.Keywords
This publication has 59 references indexed in Scilit:
- Oncologic theranostics: recognition of this concept in antigen-directed cancer therapy for colorectal cancer with anti-TAG-72 monoclonal antibodiesExpert Review of Molecular Diagnostics, 2011
- Antigen-Directed Cancer Surgery for Primary Colorectal Cancer: 15-Year Survival AnalysisAnnals of Surgical Oncology, 2011
- Site-Specific Conjugation of Monodispersed DOTA-PEGn to a Thiolated Diabody Reveals the Effect of Increasing PEG Size on Kidney Clearance and Tumor Uptake with Improved 64-Copper PET ImagingBioconjugate Chemistry, 2011
- Monodispersed DOTA-PEG–Conjugated Anti-TAG-72 Diabody Has Low Kidney Uptake and High Tumor-to-Blood Ratios Resulting in Improved64Cu PETJournal of Nuclear Medicine, 2010
- A comprehensive overview of radioguided surgery using gamma detection probe technologyWorld Journal of Surgical Oncology, 2009
- Practical method for radioactivity distribution analysis in small-animal PET cancer studiesApplied Radiation and Isotopes, 2008
- Radioimmunoguided surgery system improves survival for patients with recurrent colorectal cancerSurgery, 1995
- Preparation, characterization, and in vivo biodistribution properties of synthetically cross-linked multivalent antitumor antibody fragmentsBioconjugate Chemistry, 1993
- Intraoperative Detection of Colorectal Cancer With Radioimmunoguided Surgery and CC49, a Second-generation Monoclonal AntibodyAnnals of Surgery, 1992
- Polyethylene glycol modification of the monoclonal antibody A7 enhances its tumor localizationBiochemical and Biophysical Research Communications, 1990